Showing 3911-3920 of 10443 results for "".
FDA Approves New Melanoma Treatment with Novel MOA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dwtv-9-11-14--iloojede/19075/Merck's Keytruda, a novel PD-1 inhibitor, is approved for advanced melanoma, and a topical mole remover is being recalled.Innovations in Injectable Therapies
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/innovations-in-injectable-therapies/19089/From filling to volumizing, Julius Few, MD, FACS talks about evolving approaches to injectables and discusses new fillers, like Voluma.Understanding Male Aesthetics
https://practicaldermatology.com/topics/practice-management/understanding-male-aesthetics/19118/As the male aesthetic market continues to grow, dermatologists need to understand aesthetic differences between men and women and recognize how these will influence treatment decisions. Terrence Keaney, MD talks about Botox and neurotoxins, dermal fillers, and lasers used to treat men.CoolSculpting Circumferential Treatment Video
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/coolsculpting-circumferential-treatment-video/19442/Dr. Brian Zelickson of Edina, MN is demonstrating on a patient the benefits of using a circumferential treatment method with CoolSculpting for maximum results. Dr. Zelickson details the benefits of this type of treatment and the results his patient received.Family and Future
https://practicaldermatology.com/topics/practice-management/family-and-future/19492/The Road to Perfection
https://practicaldermatology.com/topics/practice-management/the-road-to-perfection/19491/A panel discusses various ways to improve your practice; they encourage you to "think of perfection as a continual work-in-progress."Artefill Overview
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aretfille/19521/A description of Artefill (polymethylmethacrylate (PMMA) microspheres and bovine collagen), patient assessment/consultation, injection technique for dermal filler, and aesthetic progression .Addressing the Unique Challenges of AD Patients
https://practicaldermatology.com/series/c-suite-chats/addressing-the-unique-challenges-of-ad-patients/28617/Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.Dysregulation of Type 2 Immune Pathway
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/dysregulation-of-type-2-immune-pathway/48788/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the role of type 2 inflammatory response in immune dysregulation in atopic dermatitis.Practical Dermatology Nov/Dec 2025: Page-Turner Format
https://practicaldermatology.com/issues/novemberdecember-2025/practical-dermatology-novdec-2025-page-turner-format/48997/